Solid Phase Peptide Synthesis Market Size

Solid Phase Peptide Synthesis Market size is expected to register remarkable growth rate during the forecast period i.e., between 2024-2036.  The extensive research and development associated with solid phase peptide synthesis, along with the increasing technological advancements in the development of solid phase peptide synthesizers, are expected to fuel the growth of this market. Peptides have an important role in signalling molecules in the regulation of human metabolism. With the advancement in technology, researchers realized the potential role of peptides as therapeutic agents, and consequently, research on the chemical synthesis of peptides advanced further, which led to the development of peptides using the solid phase peptide synthesis method. Peptides have diverse biological characteristics such as high biological activity, high specificity & ample chemical space, relative ease of synthesis, ready availability, and low toxicity. Therefore, they are used in numerous areas such as immunogens to produce selective peptide antibodies, binders to test the affinity of antibodies to antigens, medical imaging, and radionuclide therapy. According to the data collected from International Diabetes Federation, it is estimated that around 463 million people globally had diabetes in 2019, and by 2045, the count is projected to reach 700 million. The growth of the market can also be attributed to factors such as the increasing use of peptides in pharmaceutical drug development and in the treatment of various lifestyle disorders such as diabetes and obesity. Furthermore, due to the rapid and high-purity synthesis of peptides through solid phase peptide synthesis, the peptides can also be used in vaccine systems. The vaccines developed using peptides are highly stable and generally water-soluble. This factor is estimated to significantly boost the market growth.